WESTMINSTER RADAR
Search
My MPs
Menu

Question follow-through · 94613

Puberty Suppressing Hormones: Children

To ask the Secretary of State for Health and Social Care, if he will commit to publishing the results of the Tavistock clinical trial into puberty blockers for children.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
25 Nov 2025
Target answer date
27 Nov 2025
Answer
5 Dec 2025 · 10 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 25 Nov 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, if he will commit to publishing the results of the Tavistock clinical trial into puberty blockers for children.

  2. 27 Nov 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 5 Dec 2025

    Answer published

    There have been at least two studies relating to puberty-suppressing hormones and the Tavistock clinic. The Early pubertal suppression in a carefully selected group of adolescents with gender identity disorders study, sponsored by University College Londo...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the compatibility of the PATHWAYS trial with the requirement that clinical trials minimise foreseeable risks to child development.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether the PATHWAYS trial is insured against potential (a) loss of fertility, (b) impaired bone or cognitive development and (c) other long-term harms.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, what safeguarding measures are in place to ensure that families do not feel pressured into the PATHWAYS trial.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he made of the potential merits of (a) a feasibility study and (b) external peer review of the PATHWAYS trial.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of including a control group of children who receive no puberty suppression in the PATHWAYS trial.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, what therapeutic or psychosocial interventions must be provided before a child is considered for the PATHWAYS trial.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, for what reason the PATHWAYS trial follow up period is limited to two years.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, what long term monitoring will be in place to track adult reproductive, sexual and psychological outcomes of PATHWAYS trial participants.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, how the PATHWAYS trial will distinguish true clinical effects from placebo or expectation effects in an open label design.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether (a) detransitioners and (b) whistleblowers were consulted in the design of the PATHWAYS trial.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones: Clinical Trials

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of completing the Data Linkage Study to help inform safe PATHWAYS trial design.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Puberty Suppressing Hormones

4 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment the Department has made of the potential impact of puberty suppression on levels of likelihood of progression to cross sex hormones.